Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies

被引：56

作者：

Rondy, Marc ^{[1
]}

Kissling, Esther ^{[1
]}

Emborg, Hanne-Dorthe ^{[2
]}

Gherasim, Alin ^{[3
,4
]}

Pebody, Richard ^{[5
]}

Trebbien, Ramona ^{[6
]}

Pozo, Francisco ^{[7
]}

Larrauri, Amparo ^{[3
,4
]}

McMenamin, Jim ^{[8
]}

Valenciano, Marta ^{[1
]}

机构：

[1] EpiConcept, Paris, France

[2] Statens Serum Inst, Dept Infect Dis Epidemiol & Prevent, Copenhagen, Denmark

[3] Inst Hlth Carlos III, Natl Epidemiol Ctr, Madrid, Spain

[4] Inst Hlth Carlos III, CIBERESP, Madrid, Spain

[5] Publ Hlth England, London, England

[6] Statens Serum Inst, Dept Virus & Microbiol Special Diagnost, Natl Influenza Ctr, Copenhagen, Denmark

[7] Inst Hlth Carlos III, Inmaculada Casas Natl Ctr Microbiol, WHO, Natl Influenza Reference Lab,Natl Influenza Ctr, Madrid, Spain

[8] Hlth Protect Scotland, Glasgow, Lanark, Scotland

来源：

EUROSURVEILLANCE | 2018年 / 23卷 / 09期

关键词：

METAANALYSIS; ADULTS;

D O I：

10.2807/1560-7917.ES.2018.23.9.18-00086

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Between September 2017 and February 2018, influenza A(H1N1)pdm09, A(H3N2) and B viruses (mainly B/Yamagata, not included in 2017/18 trivalent vaccines) co-circulated in Europe. Interim results from five European studies indicate that, in all age groups, 2017/18 influenza vaccine effectiveness was 25 to 52% against any influenza, 55 to 68% against influenza A(H1N1) pdm09, -42 to 7% against influenza A(H3N2) and 36 to 54% against influenza B. 2017/18 influenza vaccine should be promoted where influenza still circulates.

引用

页码：2 / 13

页数：12

共 31 条

[1] [Anonymous], 2016, REC COMP INFL VIR VA
[2] [Anonymous], 2017, EXP OP NEUR INH PREV
[3] Repeated annual influenza vaccination and vaccine effectiveness: review of evidence
Belongia, Edward A.
Skowronski, Danuta M.
McLean, Huong Q.
Chambers, Catharine
Sundaram, Maria E.
De Serres, Gaston
[J]. EXPERT REVIEW OF VACCINES, 2017, 16 (07) : 723 - 736
[4] Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies
Belongia, Edward A.
Simpson, Melissa D.
King, Jennifer P.
Sundaram, Maria E.
Kelley, Nicholas S.
Osterholm, Michael T.
McLean, Huong Q.
[J]. LANCET INFECTIOUS DISEASES, 2016, 16 (08) : 942 - 951
[5] Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
Castilla, Jesus
Navascues, Ana
Casado, Itziar
Perez-Garcia, Alejandra
Aguinaga, Aitziber
Ezpeleta, Guillermo
Pozo, Francisco
Ezpeleta, Carmen
Martinez-Baz, Ivan
[J]. EUROSURVEILLANCE, 2018, 23 (07): : 2 - 7
[6] Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: A systematic review with meta-analyses of controlled trials
DiazGranados, Carlos A.
Denis, Martine
Plotkin, Stanley
[J]. VACCINE, 2012, 31 (01) : 49 - 57
[7] *ECDC, 2016, SEAS INFL VACC ANT U
[8] ECDC, TYP SEAS INFL VACC
[9] Influenza vaccine effectiveness in adults 65 years and older, Denmark, 2015/16-a rapid epidemiological and virological assessment
Emborg, H.
Krause, T. G.
Nielsen, L.
Thomsen, M. K.
Christiansen, C. B.
Skov, M. N.
Nielsen, X. C.
Weinreich, L. S.
Fischer, T. K.
Ronn, J.
Trebbien, R.
[J]. EUROSURVEILLANCE, 2016, 21 (14) : 2 - 7
[10] European Centre for Disease Prevention and Control (ECDC), 2009, PROT CAS CONTR STUD

← 1 2 3 4 →